Author:
Li Yiman,Li Xiaofeng,Xiao Xixi,Cheng Jie,Li Qingrui,Liu Chen,Cai Ping,Chen Wei,Zhang Huarong,Li Xiaoming
Reference35 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;H Sung;CA: a cancer journal for clinicians,2021
2. Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI;H D Zhang;Journal of clinical and translational hepatology,2023
3. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma;J Calderaro;Journal of hepatology,2019
4. Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial;K Wang;Nature medicine,2024
5. Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study;L Li;Journal of gastroenterology,2023